Mal-Drog Sp. z o.o. is based in Poland, with the head office in Szczecin. It operates in the Highway, Street, and Bridge Construction sector. It was first established on February 28, 2024. In its most recent financial highlights, the company reported a net sales revenue increase of 2.85% in 2025. A growth of 106.49% was recorded in its total assets. The net profit margin of Mal-Drog Sp. z o.o. increased by 8.11% in 2025.

Headquarters
Ul. Dabska 71
Szczecin; Zachodniopomorskie; Postal Code: 70-789

Contact Details: Purchase the Mal-Drog Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Mal-Drog Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Mal-Drog Sp. z o.o. report to view the information.

Incorporation Date:

February 28, 2024

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

70%

Purchase this report to view the information.

30%

Company Performance

Financial values in the chart are available after Mal-Drog Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

2.85%▲

Total Operating Revenue

2.85%▲

Operating Profit

28.42%▲

Net Profit/Loss for the Period

28.23%▲

Total Assets

106.49%▲

Total Equity

126.19%▲

Operating Profit Margin

8.97%▲

Net Profit Margin

8.11%▲

Return on Equity (ROE)

-42.62%▼

Quick Ratio

0.8%▲

Cash Ratio

0.58%▲

Mal-Drog Sp. z o.o. (Poland)

Similar companies

Related EMIS Industry Reports